Resources

This guide was created to support ministries of health and nongovernmental implementing partners as they develop communications strategies related to the introduction of the injectable contraceptive Sayana® Press. The document outlines communication strategies, audiences, key messages, and communications channels recommended for successful introduction of the product. For more information visit the DMPA-SC: Expanding contraceptive access and options page or email FPoptions@path.org.

This paper documents the accomplishments of the PATH-led Alliance for Cervical Cancer Prevention (ACCP). The report also presents the state of knowledge about alternative screening strategies prior to the establishment of the partnership, as well as contributions of researchers not affiliated with ACCP.

These fact sheets provide an overview of the rationale, framework, and key concepts of PATH's Enhancing Equity and Sustainability of Public-Sector Family Planning projects. This reproductive health work aims to strengthen country-led, public-sector decision-making for family planning within a total market context.

This operational assessment of Sayana® Press in Uganda examines the extent to which Sayana® Press facilitates the logistics of managing and administering injectable contraception and assesses whether providers in Uganda find benefits in this new presentation.

This qualitative study investigated the perceptions and policy implications of home and self-injection of Sayana® Press in Ethiopia’s Oromia region. Sayana® Press is the subcutaneous formulation of the three-month injectable depot medroxyprogesterone acetate (DMPA) in the Uniject™ injection system. This study did not include actual product use in humans.